Defining risk status in the first-line treatment of metastatic renal cell carcinoma Manuela SchmidingerChristoph C. Zielinski Review 08 May 2010 Pages: 961 - 968
Nonfunctional parathyroid carcinoma Wen Chao GaoCan Ping RuanQiang Wang Original Paper 05 December 2009 Pages: 969 - 974
MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 Subjects Chen MaoLi-Xin QiuQing Chen Original Paper 10 December 2009 Pages: 975 - 979
Constitutive activation of signal transducer and activator of transcription 3 regulates expression of vascular endothelial growth factor in human meningioma differentiation Mao Xiu ZhangXu ZhaoYun Shan Wang Original Paper Open access 06 January 2010 Pages: 981 - 988
The expressions of bHLH gene HES1 and HES5 in advanced ovarian serous adenocarcinomas and their prognostic significance: a retrospective clinical study Xinyu WangYajuan FuXing Xie Original Paper Open access 20 December 2009 Pages: 989 - 996
Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer Da-wei LiHua-mei TangZhi-hai Peng Original Paper 19 December 2009 Pages: 997 - 1006
FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis LingLing PanYuan HanHuang Gang Original Paper Open access 21 January 2010 Pages: 1007 - 1022
The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice Xiao-yan HeJun-xia ChenHui-min Peng Original Paper 22 December 2009 Pages: 1023 - 1028
Topoisomerase IIα expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer Christian SchindlbeckD. MayrK. Friese Original Paper 06 January 2010 Pages: 1029 - 1037
Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age Marilena VeredDan DayanShlomo Taicher Original Paper 07 January 2010 Pages: 1039 - 1048
Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer José M. del CasarGuillermo CarreñoFrancisco J. Vizoso Original Paper 30 December 2009 Pages: 1049 - 1058
Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer Kenji HashimotoAtsuo TakashimaYasuhiro Shimada Original Paper 27 December 2009 Pages: 1059 - 1064
Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors Chun-Meng WangKai HuangYing-Qiang Shi Original Paper 31 December 2009 Pages: 1065 - 1071
Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer Hyun-Chul LeeJong Gwang KimSoo-Han Jun Original Paper 01 January 2010 Pages: 1073 - 1078
Phase II biomarker trial of a multimarker diagnostic for ovarian cancer Tracey EdgellG. Martin-RoussetyG. E. Rice Original Paper Open access 16 January 2010 Pages: 1079 - 1088
Differential sensitivity of human endometrial carcinoma cells with different PTEN expression to mitogen-activated protein kinase signaling inhibits and implications for therapy Lan XiaoYue-bo YangXiao-yun Wang Original Paper 20 January 2010 Pages: 1089 - 1099
Interaction between glutathione-S-transferase polymorphisms, smoking habit, and HPV infection in cervical cancer risk Selena PalmaFlavia NovelliAntonella Testa Original Paper 13 January 2010 Pages: 1101 - 1109
The impact of smoking and polymorphic enzymes of xenobiotic metabolism on the stage of bladder tumors: a generalized ordered logistic regression analysis Sami KhedhiriNejla StambouliM. B. Slama Original Paper 09 January 2010 Pages: 1111 - 1116
